Theratechnologies Statistics
Share Statistics
Theratechnologies has 45.98M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 45.98M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 36.29M |
| Failed to Deliver (FTD) Shares | 4.68K |
| FTD / Avg. Volume | 5% |
Short Selling Information
The latest short interest is 72.20K, so 0.16% of the outstanding shares have been sold short.
| Short Interest | 72.20K |
| Short % of Shares Out | 0.16% |
| Short % of Float | 0.2% |
| Short Ratio (days to cover) | 1.06 |
Valuation Ratios
The PE ratio is -1.74 and the forward PE ratio is 11.41.
| PE Ratio | -1.74 |
| Forward PE | 11.41 |
| PS Ratio | 0.51 |
| Forward PS | 0.8 |
| PB Ratio | -2 |
| P/FCF Ratio | -5.57 |
| PEG Ratio | n/a |
Enterprise Valuation
Theratechnologies Inc. has an Enterprise Value (EV) of 66.48M.
| EV / Earnings | -2.77 |
| EV / Sales | 0.81 |
| EV / EBITDA | -6.45 |
| EV / EBIT | -6.26 |
| EV / FCF | -8.87 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of -2.83.
| Current Ratio | 1.34 |
| Quick Ratio | 1.21 |
| Debt / Equity | -2.83 |
| Total Debt / Capitalization | 154.78 |
| Cash Flow / Debt | -0.1 |
| Interest Coverage | -1.01 |
Financial Efficiency
Return on equity (ROE) is 1.15% and return on capital (ROIC) is -28.39%.
| Return on Equity (ROE) | 1.15% |
| Return on Assets (ROA) | -0.31% |
| Return on Capital (ROIC) | -28.39% |
| Revenue Per Employee | 793.83K |
| Profits Per Employee | -232.59K |
| Employee Count | 103 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 3.24 |
Taxes
| Income Tax | 421.00K |
| Effective Tax Rate | -0.02 |
Stock Price Statistics
The stock price has increased by -12.24% in the last 52 weeks. The beta is 1.73, so Theratechnologies 's price volatility has been higher than the market average.
| Beta | 1.73 |
| 52-Week Price Change | -12.24% |
| 50-Day Moving Average | 1.49 |
| 200-Day Moving Average | 1.37 |
| Relative Strength Index (RSI) | 50.71 |
| Average Volume (20 Days) | 93.65K |
Income Statement
In the last 12 months, Theratechnologies had revenue of 81.76M and earned -23.96M in profits. Earnings per share was -0.91.
| Revenue | 81.76M |
| Gross Profit | 62.13M |
| Operating Income | -10.63M |
| Net Income | -23.96M |
| EBITDA | -10.31M |
| EBIT | -10.63M |
| Earnings Per Share (EPS) | -0.91 |
Balance Sheet
The company has 34.10M in cash and 58.97M in debt, giving a net cash position of -24.87M.
| Cash & Cash Equivalents | 34.10M |
| Total Debt | 58.97M |
| Net Cash | -24.87M |
| Retained Earnings | -408.66M |
| Total Assets | 69.71M |
| Working Capital | 4.35M |
Cash Flow
In the last 12 months, operating cash flow was -5.68M and capital expenditures -1.82M, giving a free cash flow of -7.50M.
| Operating Cash Flow | -5.68M |
| Capital Expenditures | -1.82M |
| Free Cash Flow | -7.50M |
| FCF Per Share | -0.28 |
Margins
Gross margin is 75.99%, with operating and profit margins of -13% and -29.3%.
| Gross Margin | 75.99% |
| Operating Margin | -13% |
| Pretax Margin | -28.79% |
| Profit Margin | -29.3% |
| EBITDA Margin | -12.61% |
| EBIT Margin | -13% |
| FCF Margin | -9.17% |
Dividends & Yields
THTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -52.91% |
| FCF Yield | -9.5% |
Analyst Forecast
Currently there are no analyst rating for THTX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jul 31, 2023. It was a backward split with a ratio of 1:4.
| Last Split Date | Jul 31, 2023 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | -5.85 |
| Piotroski F-Score | 4 |